Aukea Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-12-2024
- Paid Up Capital ₹ 49.50 K
as on 29-12-2024
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -77.29%
(FY 2022)
- Profit -201.73%
(FY 2022)
- Ebitda -114.35%
(FY 2022)
- Net Worth -31.83%
(FY 2022)
- Total Assets 38.96%
(FY 2022)
About Aukea Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 49.50 K , as per Ministry of Corporate Affairs (MCA) records.
Amrut Chaudhari, Mukeshkumar Soni, and Vinay Khandelwal serve as directors at the Company.
- CIN/LLPIN
U24303GJ2019PTC107528
- Company No.
107528
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Apr 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aukea Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Khandelwal  | Director | 09-Apr-2019 | Current |
| Amrut Chaudhari | Director | 09-Apr-2019 | Current |
| Mukeshkumar Soni | Director | 09-Apr-2019 | Current |
Financial Performance of Aukea Life Sciences.
Aukea Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 77.29% decrease. The company also saw a substantial fall in profitability, with a 201.73% decrease in profit. The company's net worth observed a substantial decline by a decrease of 31.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aukea Life Sciences?
Unlock access to Aukea Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Abhilasha Pharma Private LimitedActive 19 years 19 daysAmrut Chaudhari and Mukeshkumar Soni are mutual person
- Abhelfen Life Science Private LimitedActive 4 years 7 months
Amrut Chaudhari and Mukeshkumar Soni are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aukea Life Sciences?
Unlock and access historical data on people associated with Aukea Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aukea Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aukea Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
